查看購物車
  • English
  • Japanese
  • Korean
CRISPR和Cas基因市場規模及預測（2021-2031年），全球及區域佔有率、趨勢、成長機會分析報告：按產品/服務、應用、最終用戶和地區分類
市場調查報告書
商品編碼
1938273

CRISPR和Cas基因市場規模及預測（2021-2031年），全球及區域佔有率、趨勢、成長機會分析報告：按產品/服務、應用、最終用戶和地區分類

CRISPR and Cas Gene Market Size and Forecast 2021-2031, Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Product & Service, Application, End User, and Geography
出版日期: | 出版商: The Insight Partners | 英文 318 Pages | 訂單完成後即時交付

價格
CRISPR和Cas基因編輯市場規模預計將從2024年的41.3億美元成長到2031年的180.4億美元，2025年至2031年的複合年成長率（CAGR）為23.4%。遺傳疾病的日益增加、研究經費和投資的增加以及精準醫療需求的激增是推動CRISPR和Cas基因編輯市場規模擴張的主要因素。此外，向下一代編輯技術的演進預計將在不久的將來為CRISPR和Cas基因編輯市場帶來新的趨勢。

CRISPR-Cas基因編輯技術已經超越了傳統的Cas9核酸酶。包括鹼基編輯、先導編輯和RNA/表觀遺傳編輯在內的新一代工具，能夠在保證高精度的同時降低風險，並推動治療方法創新。這些技術可以修復90%已知的致病突變。由David Liu實驗室率先開發的鹼基編輯技術，惰性的Cas9與脫氨酶結合，將C*G鹼基對轉化為T*A鹼基對，或將A*T鹼基對轉化為G*C鹼基對。 Beam Therapeutics公司已利用鹼基編輯器標靶治療鐮狀細胞貧血症（SCD），在造血幹細胞中實現了高達80%的校正效率，且插入/缺失（indel）極少。

Prime 編輯技術結合了 Cas9 酶、逆轉錄酶和引導編輯的 RNA (pegRNA)，能夠實現「搜尋替換」式的基因編輯，例如插入或刪除長達 44 個鹼基對的 DNA 區域。 2020 年，Prime Medicine 公司的這項技術在患者來源的類器官中展示了功能性矯正，用於治療囊腫纖維化。 2025 年 2 月，全球首個針對罕見代謝疾病的 Prime 編輯人體臨床試驗啟動，結果顯示其修飾效率在 50% 至 70% 之間。截至 2025 年 4 月，基於這些方法的 98 項臨床試驗正在進行中，預示著安全且用途廣泛的基因療法新時代的到來。新一代基因編輯技術標誌著 CRISPR 領域的模式轉移。這些創新有望為遺傳疾病、癌症和感染疾病提供更安全、更通用的治療方法，並正在成為 CRISPR 和 Cas 基因市場的重要發展趨勢。

最終用戶洞察

エンドユーザー別に見ると、CRISPRおよびCas遺伝子市場は、バイオテクノロレーーオテクノロレ機關,政府系研究機關、受託研究機構（CRO）および醫薬品開発受託製造廠商（CDMO）に區分されます。 2024年時點で、バイオテクノロジー,制薬企業セグメントが最大の市場shiェaを佔ぁントが最大の市場shiェaを佔ぁまぁぁ。このセグメントの成長は、CRISPRを活用した新規治療方法の開発に向け、臨床開発、夥伴關係、商業化への大規模投資によって牽引されています。その一例として、Vertex製藥社とCRISPR治療社の共同開発によるCasgevy（エクサガムグロゲン,オートテムセル）が挙げられます。これは、鐮狀赤血球症および輸血依存性BETAサラセミア治療における初のFDA核准CRISPRapuroチです。この手法は造血幹細胞を精密に編集することで、病人様に長期的な利益をもたらします。同樣，Intellia Therapeutics 等公司正在將其候選藥物 NTLA-2002（一種基於 CRISPR 的遺傳性血管性水腫體內治療方法）轉移到 2025 年的 3 期臨床試驗，在降低癲癇發作頻率方面取得了可喜的結果。另一個例子是Verve Therapeutics公司的候選藥物CTX-310，該藥物靶向ANGPTL3，旨在降低低密度脂蛋白膽固醇和三酸甘油酯水平，預計將於2025年公佈令人鼓舞的I期臨床試驗數據。這些不斷增加的臨床試驗和核准，在個人化醫療的巨大需求、遺傳疾病發病率的上升以及為改進CRISPR技術而進行的適當收購活動的推動下，該領域正在蓬勃發展。這使得生物技術公司和大型製藥公司成為下一代基因療法的領導者，並推動了CRISPR和Cas基因市場的成長。

目錄

第1章執行摘要

  • 分析師市場展望
  • 市場吸引力

第2章：CRISPR和Cas基因市場的市場概況

  • 價值鏈分析
  • 供應鏈分析
    • 製造商/供應商列表
    • 潛在客戶名單（最多 50 家公司）
  • PEST分析
  • 人工智慧（AI）的影響
  • 產品或技術藍圖
  • 永續性與ESG趨勢
  • 法律規範

第3章 競爭情勢

  • 主要企業進行企業標竿分析
  • 2024年主要企業市佔率分析
  • 市場集中度

4. CRISPR和Cas基因市場－關鍵市場動態

  • 市場促進因素
  • 市場限制
  • 市場機遇
  • 未來趨勢
  • 促進因素和抑制因素的影響

5. CRISPR和Cas基因市場－全球市場分析

  • CRISPR和Cas基因市場收入（2021-2031年）
  • CRISPR和Cas基因市場預測與分析

6. CRISPR和Cas基因市場按產品和服務分類的收入分析

  • CRISPR和Cas基因市場預測及產品和服務分析
    • 產品
      • 產品：CRISPR和Cas基因市場－收入，2021-2031年
    • 服務
      • 服務：CRISPR 和 Cas 基因市場 - 收入，2021-2031 年

7. CRISPR和Cas基因市場收入分析－按應用領域分類

  • CRISPR和Cas基因市場：按應用分類的預測和分析
    • 生物醫學
      • 生物醫學領域：CRISPR和Cas基因市場－收入，2021-2031年
    • 農業
      • 農業：CRISPR和Cas基因市場－收入，2021-2031年

8. CRISPR和Cas基因市場按最終用戶分類的收入分析

  • CRISPR和Cas基因市場預測和最終用戶分析
    • 生物技術和製藥公司
      • 生物技術和製藥公司：CRISPR和Cas基因市場－收入，2021-2031年
    • 學術和政府研究機構
      • 學術界與政府研究：CRISPR和Cas基因市場－收入，2021-2031年
    • 受託研究機構（CRO）和合約研發生產力組織（CDMO）
      • 受託研究機構(CRO) 和合約研發生產力組織 (CDMO)：CRISPR 和 Cas 基因市場 - 收入，2021-2031 年

9. CRISPR和Cas基因市場－區域分析

  • 北美洲
    • 產品和服務
    • 產品和服務的產品
    • 產品和服務
    • 目的
    • 用於生物醫學應用
    • 最終用戶
    • 針對美國市場
    • 加拿大市場
    • 墨西哥市場
  • 歐洲
    • 英國市場
    • 德國市場
    • 法國市場
    • 義大利市場
    • 西班牙市場
    • 其他歐洲市場
  • 亞太地區
    • 中國市場
    • 日本市場
    • 印度市場
    • 澳洲市場
    • 韓國市場
    • 亞太地區的其他國家
  • 中東和非洲市場
    • 沙烏地阿拉伯市場
    • 南非市場
    • 阿拉伯聯合大公國市場
    • 其他中東和非洲市場
  • 南美洲和中美洲
    • 南美洲和拉丁美洲市場
      • 巴西市場
      • 阿根廷市場
      • 其他南美洲和中美洲市場

第10章：CRISPR和Cas基因市場產業概況

11. CRISPR 和 Cas 基因市場－主要企業概況

  • CRISPR Therapeutics
  • Horizon Discovery Group plc.
  • Thermo Fisher Scientific Inc
  • Merck KGaA
  • Integrated DNA Technologies Inc.
  • QIAGEN NV
  • Takara Bio Inc
  • Synthego Holdings LLC
  • GenScript Biotech Corporation
  • Editas Medicine Inc

第12章：待分析的其他公司名單

  • 待分析的其他公司名單

第13章附錄

Product Code: TIPRE00016686

The CRISPR and Cas gene market size is expected to grow from US$ 4.13 billion in 2024 to US$ 18.04 billion by 2031; it is projected to register a CAGR of 23.4% during 2025-2031. The rising prevalence of genetic disorders, growing research funding and investments, and surging demand for precision medicine are noteworthy factors contributing to the expansion of the CRISPR and Cas gene market size. Additionally, the evolution toward next-gen editing is projected to bring new CRISPR and Cas gene market trends in the near future.

The CRISPR-Cas gene editing landscape is evolving beyond traditional Cas9 nucleases. Next-generation tools such as base editing, prime editing, and RNA/epigenetic editing offer precision without such risks, driving therapeutic breakthroughs. These techniques can fix 90% of known disease-causing mutations. Base editing, pioneered by David Liu's lab, fuses a deactivated Cas9 with deaminases to convert C*G to T*A or A*T to G*C base pairs. Beam Therapeutics employs base editors to target SCD, achieving up to 80% correction efficiency in hematopoietic stem cells with minimal indels.

Prime editing combines the use of the Cas9 nickase with a reverse transcriptase and a prime editing guide RNA (pegRNA) to enable "search-and-replace" modification, such as insertions and deletions, of a DNA span extending to 44 bp. In 2020, Prime Medicine's technology demonstrated functional correction within patient organoids for the treatment of cystic fibrosis. In February 2025, it carried out first-in-human prime editing in a rare metabolic disorder and showed a modification efficiency ranging between 50%-70%. As of April 2025, there are 98 clinical trials based on these modalities that foretell a new age of safe and versatile gene therapies. The next generation of gene-editing technologies signals a paradigm shift within the CRISPR area. These innovations promise safer, more versatile therapies for genetic diseases, cancer, and infectious disorders, thereby emerging as a significant trend in the CRISPR and Cas gene market.

End User-Based Insights

Based on end user, the CRISPR and Cas gene market is segmented into biotechnology and pharmaceutical companies, academics and government research institutes, and contract research organizations and CDMOs. The biotechnology and pharmaceutical companies segment held the largest CRISPR and Cas gene market share in 2024. The growth in this segment is driven by their massive investments in clinical development, partnerships, and commercialization to unlock new therapies using CRISPR. One such example is the collaboration between Vertex Pharmaceuticals and CRISPR Therapeutics to create Casgevy (exagamglogene autotemcel), marking the first FDA-approved CRISPR-mediated approach to treating sickle cell disease and transfusion-dependent beta-thalassemia. This approach offers long-term patient benefits by precisely editing hematopoietic stem cells. Similarly, companies like Intellia Therapeutics moved their candidate, NTLA-2002, a CRISPR-based in vivo approach for hereditary angioedema, to a Phase 3 clinical trial in 2025, with encouraging reductions in attack rates. Other examples include Verve Therapeutics and their CTX-310 candidate, which aims to reduce LDL cholesterol and triglycerides by targeting ANGPTL3, with promising phase 1 clinical trial data expected in 2025. This increase in clinical trials and approval highlights that this segment is also witnessing growth driven by their huge requirements for personalized healthcare, increasing incidence rates for genetic disorders, and appropriate acquisition to improve CRISPR technology, making biotech and pharma giants leaders in next-generation gene therapies, thereby fueling the CRISPR and Cas gene market growth.

The World Health Organization and the FDA are among the primary and secondary sources referred to while preparing the CRISPR and Cas gene market report.

Table Of Contents

1. Executive Summary

  • 1.1 Analyst Market Outlook
  • 1.2 Market Attractiveness

2. CRISPR and Cas Gene Market Landscape

  • 2.1 Overview
  • 2.2 Value Chain Analysis
  • 2.3 Supply Chain Analysis
    • 2.3.1 List of Manufacturers/Suppliers
    • 2.3.2 List of Potential Customers (Upto 50)
  • 2.4 PEST Analysis
  • 2.5 Impact of Artificial Intelligence (AI)
  • 2.6 Product or Technology Roadmap
  • 2.7 Sustainability and ESG Trends
  • 2.8 Regulatory Framework

3. Competitive Landscape

  • 3.1 Company Benchmarking by Key Players
  • 3.2 Market Share Analysis, 2024 - By Key Players
  • 3.3 Market Concentration

4. CRISPR and Cas Gene Market - Key Industry Dynamics

  • 4.1 Market Drivers
  • 4.2 Market Restraints
  • 4.3 Market Opportunities
  • 4.4 Future Trends
  • 4.5 Impact of Drivers and Restraints

5. CRISPR and Cas Gene Market - Global Market Analysis

  • 5.1 CRISPR and Cas Gene Market Revenue (US$ Million), 2021-2031
  • 5.2 CRISPR and Cas Gene Market Forecast and Analysis

6. CRISPR and Cas Gene Market Revenue Analysis -Product And Service

  • 6.1 CRISPR and Cas Gene Market Forecasts and Analysis by Product And Service
    • 6.1.1 Product
      • 6.1.1.1 Overview
      • 6.1.1.2 Product: CRISPR and Cas Gene Market -Revenue, 2021-2031 (US$ Million)
    • 6.1.2 Services
      • 6.1.2.1 Overview
      • 6.1.2.2 Services: CRISPR and Cas Gene Market -Revenue, 2021-2031 (US$ Million)

7. CRISPR and Cas Gene Market Revenue Analysis -Application

  • 7.1 CRISPR and Cas Gene Market Forecasts and Analysis by Application
    • 7.1.1 Biomedical
      • 7.1.1.1 Overview
      • 7.1.1.2 Biomedical: CRISPR and Cas Gene Market -Revenue, 2021-2031 (US$ Million)
    • 7.1.2 Agriculture
      • 7.1.2.1 Overview
      • 7.1.2.2 Agriculture: CRISPR and Cas Gene Market -Revenue, 2021-2031 (US$ Million)

8. CRISPR and Cas Gene Market Revenue Analysis -End User

  • 8.1 CRISPR and Cas Gene Market Forecasts and Analysis by End User
    • 8.1.1 Biotechnology and Pharmaceutical Companies
      • 8.1.1.1 Overview
      • 8.1.1.2 Biotechnology and Pharmaceutical Companies: CRISPR and Cas Gene Market -Revenue, 2021-2031 (US$ Million)
    • 8.1.2 Academics and Government Research Institutes
      • 8.1.2.1 Overview
      • 8.1.2.2 Academics and Government Research Institutes: CRISPR and Cas Gene Market -Revenue, 2021-2031 (US$ Million)
    • 8.1.3 Contract Research Organizations (CRO) and CDMOs
      • 8.1.3.1 Overview
      • 8.1.3.2 Contract Research Organizations (CRO) and CDMOs: CRISPR and Cas Gene Market -Revenue, 2021-2031 (US$ Million)

9. CRISPR and Cas Gene Market - Geographical Analysis

  • 9.1 North America
    • 9.1.1 North America CRISPR and Cas Gene Market Overview
    • 9.1.2 North America: CRISPR and Cas Gene Market Revenue and Forecasts, 2021-2031 (US$ Million)
    • 9.1.3 North America: CRISPR and Cas Gene Market- By Segmentation
      • 9.1.3.1 Product And Service
      • 9.1.3.2 Product For Product And Service
      • 9.1.3.3 Services For Product And Service
      • 9.1.3.4 Application
      • 9.1.3.5 Biomedical For Application
      • 9.1.3.6 End User
    • 9.1.4 North America: CRISPR and Cas Gene Market Breakdown by Countries
      • 9.1.4.1 United States Market
        • 9.1.4.1.1 United States: CRISPR and Cas Gene Market Revenue and Forecasts, 2021-2031 (US$ Million)
        • 9.1.4.1.2 United States: CRISPR and Cas Gene Market- By Segmentation
          • 9.1.4.1.2.1 Product And Service
          • 9.1.4.1.2.2 Product For Product And Service
          • 9.1.4.1.2.3 Services For Product And Service
          • 9.1.4.1.2.4 Application
          • 9.1.4.1.2.5 Biomedical For Application
          • 9.1.4.1.2.6 End User
      • 9.1.4.2 Canada Market
        • 9.1.4.2.1 Canada: CRISPR and Cas Gene Market Revenue and Forecasts, 2021-2031 (US$ Million)
        • 9.1.4.2.2 Canada: CRISPR and Cas Gene Market- By Segmentation
          • 9.1.4.2.2.1 Product And Service
          • 9.1.4.2.2.2 Product For Product And Service
          • 9.1.4.2.2.3 Services For Product And Service
          • 9.1.4.2.2.4 Application
          • 9.1.4.2.2.5 Biomedical For Application
          • 9.1.4.2.2.6 End User
      • 9.1.4.3 Mexico Market
        • 9.1.4.3.1 Mexico: CRISPR and Cas Gene Market Revenue and Forecasts, 2021-2031 (US$ Million)
        • 9.1.4.3.2 Mexico: CRISPR and Cas Gene Market- By Segmentation
          • 9.1.4.3.2.1 Product And Service
          • 9.1.4.3.2.2 Product For Product And Service
          • 9.1.4.3.2.3 Services For Product And Service
          • 9.1.4.3.2.4 Application
          • 9.1.4.3.2.5 Biomedical For Application
          • 9.1.4.3.2.6 End User
  • 9.2 Europe
    • 9.2.1 Europe CRISPR and Cas Gene Market Overview
    • 9.2.2 Europe: CRISPR and Cas Gene Market Revenue and Forecasts, 2021-2031 (US$ Million)
    • 9.2.3 Europe: CRISPR and Cas Gene Market- By Segmentation
      • 9.2.3.1 Product And Service
      • 9.2.3.2 Product For Product And Service
      • 9.2.3.3 Services For Product And Service
      • 9.2.3.4 Application
      • 9.2.3.5 Biomedical For Application
      • 9.2.3.6 End User
    • 9.2.4 Europe: CRISPR and Cas Gene Market Breakdown by Countries
      • 9.2.4.1 United Kingdom Market
        • 9.2.4.1.1 United Kingdom: CRISPR and Cas Gene Market Revenue and Forecasts, 2021-2031 (US$ Million)
        • 9.2.4.1.2 United Kingdom: CRISPR and Cas Gene Market- By Segmentation
          • 9.2.4.1.2.1 Product And Service
          • 9.2.4.1.2.2 Product For Product And Service
          • 9.2.4.1.2.3 Services For Product And Service
          • 9.2.4.1.2.4 Application
          • 9.2.4.1.2.5 Biomedical For Application
          • 9.2.4.1.2.6 End User
      • 9.2.4.2 Germany Market
        • 9.2.4.2.1 Germany: CRISPR and Cas Gene Market Revenue and Forecasts, 2021-2031 (US$ Million)
        • 9.2.4.2.2 Germany: CRISPR and Cas Gene Market- By Segmentation
          • 9.2.4.2.2.1 Product And Service
          • 9.2.4.2.2.2 Product For Product And Service
          • 9.2.4.2.2.3 Services For Product And Service
          • 9.2.4.2.2.4 Application
          • 9.2.4.2.2.5 Biomedical For Application
          • 9.2.4.2.2.6 End User
      • 9.2.4.3 France Market
        • 9.2.4.3.1 France: CRISPR and Cas Gene Market Revenue and Forecasts, 2021-2031 (US$ Million)
        • 9.2.4.3.2 France: CRISPR and Cas Gene Market- By Segmentation
          • 9.2.4.3.2.1 Product And Service
          • 9.2.4.3.2.2 Product For Product And Service
          • 9.2.4.3.2.3 Services For Product And Service
          • 9.2.4.3.2.4 Application
          • 9.2.4.3.2.5 Biomedical For Application
          • 9.2.4.3.2.6 End User
      • 9.2.4.4 Italy Market
        • 9.2.4.4.1 Italy: CRISPR and Cas Gene Market Revenue and Forecasts, 2021-2031 (US$ Million)
        • 9.2.4.4.2 Italy: CRISPR and Cas Gene Market- By Segmentation
          • 9.2.4.4.2.1 Product And Service
          • 9.2.4.4.2.2 Product For Product And Service
          • 9.2.4.4.2.3 Services For Product And Service
          • 9.2.4.4.2.4 Application
          • 9.2.4.4.2.5 Biomedical For Application
          • 9.2.4.4.2.6 End User
      • 9.2.4.5 Spain Market
        • 9.2.4.5.1 Spain: CRISPR and Cas Gene Market Revenue and Forecasts, 2021-2031 (US$ Million)
        • 9.2.4.5.2 Spain: CRISPR and Cas Gene Market- By Segmentation
          • 9.2.4.5.2.1 Product And Service
          • 9.2.4.5.2.2 Product For Product And Service
          • 9.2.4.5.2.3 Services For Product And Service
          • 9.2.4.5.2.4 Application
          • 9.2.4.5.2.5 Biomedical For Application
          • 9.2.4.5.2.6 End User
      • 9.2.4.6 Rest of Europe Market
        • 9.2.4.6.1 Rest of Europe: CRISPR and Cas Gene Market Revenue and Forecasts, 2021-2031 (US$ Million)
        • 9.2.4.6.2 Rest of Europe: CRISPR and Cas Gene Market- By Segmentation
          • 9.2.4.6.2.1 Product And Service
          • 9.2.4.6.2.2 Product For Product And Service
          • 9.2.4.6.2.3 Services For Product And Service
          • 9.2.4.6.2.4 Application
          • 9.2.4.6.2.5 Biomedical For Application
          • 9.2.4.6.2.6 End User
  • 9.3 Asia Pacific
    • 9.3.1 Asia Pacific CRISPR and Cas Gene Market Overview
    • 9.3.2 Asia Pacific: CRISPR and Cas Gene Market Revenue and Forecasts, 2021-2031 (US$ Million)
    • 9.3.3 Asia Pacific: CRISPR and Cas Gene Market- By Segmentation
      • 9.3.3.1 Product And Service
      • 9.3.3.2 Product For Product And Service
      • 9.3.3.3 Services For Product And Service
      • 9.3.3.4 Application
      • 9.3.3.5 Biomedical For Application
      • 9.3.3.6 End User
    • 9.3.4 Asia Pacific: CRISPR and Cas Gene Market Breakdown by Countries
      • 9.3.4.1 China Market
        • 9.3.4.1.1 China: CRISPR and Cas Gene Market Revenue and Forecasts, 2021-2031 (US$ Million)
        • 9.3.4.1.2 China: CRISPR and Cas Gene Market- By Segmentation
          • 9.3.4.1.2.1 Product And Service
          • 9.3.4.1.2.2 Product For Product And Service
          • 9.3.4.1.2.3 Services For Product And Service
          • 9.3.4.1.2.4 Application
          • 9.3.4.1.2.5 Biomedical For Application
          • 9.3.4.1.2.6 End User
      • 9.3.4.2 Japan Market
        • 9.3.4.2.1 Japan: CRISPR and Cas Gene Market Revenue and Forecasts, 2021-2031 (US$ Million)
        • 9.3.4.2.2 Japan: CRISPR and Cas Gene Market- By Segmentation
          • 9.3.4.2.2.1 Product And Service
          • 9.3.4.2.2.2 Product For Product And Service
          • 9.3.4.2.2.3 Services For Product And Service
          • 9.3.4.2.2.4 Application
          • 9.3.4.2.2.5 Biomedical For Application
          • 9.3.4.2.2.6 End User
      • 9.3.4.3 India Market
        • 9.3.4.3.1 India: CRISPR and Cas Gene Market Revenue and Forecasts, 2021-2031 (US$ Million)
        • 9.3.4.3.2 India: CRISPR and Cas Gene Market- By Segmentation
          • 9.3.4.3.2.1 Product And Service
          • 9.3.4.3.2.2 Product For Product And Service
          • 9.3.4.3.2.3 Services For Product And Service
          • 9.3.4.3.2.4 Application
          • 9.3.4.3.2.5 Biomedical For Application
          • 9.3.4.3.2.6 End User
      • 9.3.4.4 Australia Market
        • 9.3.4.4.1 Australia: CRISPR and Cas Gene Market Revenue and Forecasts, 2021-2031 (US$ Million)
        • 9.3.4.4.2 Australia: CRISPR and Cas Gene Market- By Segmentation
          • 9.3.4.4.2.1 Product And Service
          • 9.3.4.4.2.2 Product For Product And Service
          • 9.3.4.4.2.3 Services For Product And Service
          • 9.3.4.4.2.4 Application
          • 9.3.4.4.2.5 Biomedical For Application
          • 9.3.4.4.2.6 End User
      • 9.3.4.5 South Korea Market
        • 9.3.4.5.1 South Korea: CRISPR and Cas Gene Market Revenue and Forecasts, 2021-2031 (US$ Million)
        • 9.3.4.5.2 South Korea: CRISPR and Cas Gene Market- By Segmentation
          • 9.3.4.5.2.1 Product And Service
          • 9.3.4.5.2.2 Product For Product And Service
          • 9.3.4.5.2.3 Services For Product And Service
          • 9.3.4.5.2.4 Application
          • 9.3.4.5.2.5 Biomedical For Application
          • 9.3.4.5.2.6 End User
      • 9.3.4.6 Rest of APAC Market
        • 9.3.4.6.1 Rest of APAC: CRISPR and Cas Gene Market Revenue and Forecasts, 2021-2031 (US$ Million)
        • 9.3.4.6.2 Rest of APAC: CRISPR and Cas Gene Market- By Segmentation
          • 9.3.4.6.2.1 Product And Service
          • 9.3.4.6.2.2 Product For Product And Service
          • 9.3.4.6.2.3 Services For Product And Service
          • 9.3.4.6.2.4 Application
          • 9.3.4.6.2.5 Biomedical For Application
          • 9.3.4.6.2.6 End User
  • 9.4 Middle East and Africa
    • 9.4.1 Middle East and Africa CRISPR and Cas Gene Market Overview
    • 9.4.2 Middle East and Africa: CRISPR and Cas Gene Market Revenue and Forecasts, 2021-2031 (US$ Million)
    • 9.4.3 Middle East and Africa: CRISPR and Cas Gene Market- By Segmentation
      • 9.4.3.1 Product And Service
      • 9.4.3.2 Product For Product And Service
      • 9.4.3.3 Services For Product And Service
      • 9.4.3.4 Application
      • 9.4.3.5 Biomedical For Application
      • 9.4.3.6 End User
    • 9.4.4 Middle East and Africa: CRISPR and Cas Gene Market Breakdown by Countries
      • 9.4.4.1 Saudi Arabia Market
        • 9.4.4.1.1 Saudi Arabia: CRISPR and Cas Gene Market Revenue and Forecasts, 2021-2031 (US$ Million)
        • 9.4.4.1.2 Saudi Arabia: CRISPR and Cas Gene Market- By Segmentation
          • 9.4.4.1.2.1 Product And Service
          • 9.4.4.1.2.2 Product For Product And Service
          • 9.4.4.1.2.3 Services For Product And Service
          • 9.4.4.1.2.4 Application
          • 9.4.4.1.2.5 Biomedical For Application
          • 9.4.4.1.2.6 End User
      • 9.4.4.2 South Africa Market
        • 9.4.4.2.1 South Africa: CRISPR and Cas Gene Market Revenue and Forecasts, 2021-2031 (US$ Million)
        • 9.4.4.2.2 South Africa: CRISPR and Cas Gene Market- By Segmentation
          • 9.4.4.2.2.1 Product And Service
          • 9.4.4.2.2.2 Product For Product And Service
          • 9.4.4.2.2.3 Services For Product And Service
          • 9.4.4.2.2.4 Application
          • 9.4.4.2.2.5 Biomedical For Application
          • 9.4.4.2.2.6 End User
      • 9.4.4.3 United Arab Emirates Market
        • 9.4.4.3.1 United Arab Emirates: CRISPR and Cas Gene Market Revenue and Forecasts, 2021-2031 (US$ Million)
        • 9.4.4.3.2 United Arab Emirates: CRISPR and Cas Gene Market- By Segmentation
          • 9.4.4.3.2.1 Product And Service
          • 9.4.4.3.2.2 Product For Product And Service
          • 9.4.4.3.2.3 Services For Product And Service
          • 9.4.4.3.2.4 Application
          • 9.4.4.3.2.5 Biomedical For Application
          • 9.4.4.3.2.6 End User
      • 9.4.4.4 Rest of Middle East and Africa Market
        • 9.4.4.4.1 Rest of Middle East and Africa: CRISPR and Cas Gene Market Revenue and Forecasts, 2021-2031 (US$ Million)
        • 9.4.4.4.2 Rest of Middle East and Africa: CRISPR and Cas Gene Market- By Segmentation
          • 9.4.4.4.2.1 Product And Service
          • 9.4.4.4.2.2 Product For Product And Service
          • 9.4.4.4.2.3 Services For Product And Service
          • 9.4.4.4.2.4 Application
          • 9.4.4.4.2.5 Biomedical For Application
          • 9.4.4.4.2.6 End User
  • 9.5 South and Central America
    • 9.5.1 South and Central America CRISPR and Cas Gene Market Overview
    • 9.5.2 South and Central America: CRISPR and Cas Gene Market Revenue and Forecasts, 2021-2031 (US$ Million)
    • 9.5.3 South and Central America: CRISPR and Cas Gene Market- By Segmentation
      • 9.5.3.1 Product And Service
      • 9.5.3.2 Product For Product And Service
      • 9.5.3.3 Services For Product And Service
      • 9.5.3.4 Application
      • 9.5.3.5 Biomedical For Application
      • 9.5.3.6 End User
    • 9.5.4 South and Central America: CRISPR and Cas Gene Market Breakdown by Countries
      • 9.5.4.1 Brazil Market
        • 9.5.4.1.1 Brazil: CRISPR and Cas Gene Market Revenue and Forecasts, 2021-2031 (US$ Million)
        • 9.5.4.1.2 Brazil: CRISPR and Cas Gene Market- By Segmentation
          • 9.5.4.1.2.1 Product And Service
          • 9.5.4.1.2.2 Product For Product And Service
          • 9.5.4.1.2.3 Services For Product And Service
          • 9.5.4.1.2.4 Application
          • 9.5.4.1.2.5 Biomedical For Application
          • 9.5.4.1.2.6 End User
      • 9.5.4.2 Argentina Market
        • 9.5.4.2.1 Argentina: CRISPR and Cas Gene Market Revenue and Forecasts, 2021-2031 (US$ Million)
        • 9.5.4.2.2 Argentina: CRISPR and Cas Gene Market- By Segmentation
          • 9.5.4.2.2.1 Product And Service
          • 9.5.4.2.2.2 Product For Product And Service
          • 9.5.4.2.2.3 Services For Product And Service
          • 9.5.4.2.2.4 Application
          • 9.5.4.2.2.5 Biomedical For Application
          • 9.5.4.2.2.6 End User
      • 9.5.4.3 Rest of South and Central America Market
        • 9.5.4.3.1 Rest of South and Central America: CRISPR and Cas Gene Market Revenue and Forecasts, 2021-2031 (US$ Million)
        • 9.5.4.3.2 Rest of South and Central America: CRISPR and Cas Gene Market- By Segmentation
          • 9.5.4.3.2.1 Product And Service
          • 9.5.4.3.2.2 Product For Product And Service
          • 9.5.4.3.2.3 Services For Product And Service
          • 9.5.4.3.2.4 Application
          • 9.5.4.3.2.5 Biomedical For Application
          • 9.5.4.3.2.6 End User

10. CRISPR and Cas Gene Market Industry Landscape

11. CRISPR and Cas Gene Market - Key Company Profiles

  • 11.1 CRISPR Therapeutics
    • 11.1.1 Key Facts
    • 11.1.2 Business Description
    • 11.1.3 Products and Services
    • 11.1.4 Financial Overview
    • 11.1.5 SWOT Analysis
    • 11.1.6 Key Developments
  • 11.2 Horizon Discovery Group plc.
    • 11.2.1 Key Facts
    • 11.2.2 Business Description
    • 11.2.3 Products and Services
    • 11.2.4 Financial Overview
    • 11.2.5 SWOT Analysis
    • 11.2.6 Key Developments
  • 11.3 Thermo Fisher Scientific Inc
    • 11.3.1 Key Facts
    • 11.3.2 Business Description
    • 11.3.3 Products and Services
    • 11.3.4 Financial Overview
    • 11.3.5 SWOT Analysis
    • 11.3.6 Key Developments
  • 11.4 Merck KGaA
    • 11.4.1 Key Facts
    • 11.4.2 Business Description
    • 11.4.3 Products and Services
    • 11.4.4 Financial Overview
    • 11.4.5 SWOT Analysis
    • 11.4.6 Key Developments
  • 11.5 Integrated DNA Technologies Inc.
    • 11.5.1 Key Facts
    • 11.5.2 Business Description
    • 11.5.3 Products and Services
    • 11.5.4 Financial Overview
    • 11.5.5 SWOT Analysis
    • 11.5.6 Key Developments
  • 11.6 QIAGEN NV
    • 11.6.1 Key Facts
    • 11.6.2 Business Description
    • 11.6.3 Products and Services
    • 11.6.4 Financial Overview
    • 11.6.5 SWOT Analysis
    • 11.6.6 Key Developments
  • 11.7 Takara Bio Inc
    • 11.7.1 Key Facts
    • 11.7.2 Business Description
    • 11.7.3 Products and Services
    • 11.7.4 Financial Overview
    • 11.7.5 SWOT Analysis
    • 11.7.6 Key Developments
  • 11.8 Synthego Holdings LLC
    • 11.8.1 Key Facts
    • 11.8.2 Business Description
    • 11.8.3 Products and Services
    • 11.8.4 Financial Overview
    • 11.8.5 SWOT Analysis
    • 11.8.6 Key Developments
  • 11.9 GenScript Biotech Corporation
    • 11.9.1 Key Facts
    • 11.9.2 Business Description
    • 11.9.3 Products and Services
    • 11.9.4 Financial Overview
    • 11.9.5 SWOT Analysis
    • 11.9.6 Key Developments
  • 11.10 Editas Medicine Inc
    • 11.10.1 Key Facts
    • 11.10.2 Business Description
    • 11.10.3 Products and Services
    • 11.10.4 Financial Overview
    • 11.10.5 SWOT Analysis
    • 11.10.6 Key Developments

12. List of Additional Companies Analyzed

  • 12.1 List of Additional Companies Analyzed

13. Appendix

  • 13.1 Glossary
  • 13.2 Research Methodology and Approach
    • 13.2.1 Secondary Research
    • 13.2.2 Primary Research
    • 13.2.3 Market Estimation Approach
      • 13.2.3.1 Supply Side Analysis
      • 13.2.3.2 Demand Side Analysis
    • 13.2.4 Research Assumptions and Limitations
    • 13.2.5 Currency Conversion
  • 13.3 About The Insight Partners
  • 13.4 Market Intelligence Cloud

List Of Tables

  • Table 1. List of Regulatory Bodies and Organizations
  • Table 2. Ease of Doing Business: Key Country Rankings
  • Table 3. Market Share Analysis, 2024 - By Key Players
  • Table 4. CRISPR and Cas Gene Market - Revenue, 2021-2024(US$ Million)
  • Table 5. CRISPR and Cas Gene Market - Revenue Forecast, 2025-2031(US$ Million)
  • Table 6. CRISPR and Cas Gene Market - Revenue, 2021-2024(US$ Million) - by Product And Service
  • Table 7. CRISPR and Cas Gene Market - Revenue Forecast, 2025-2031(US$ Million) - by Product And Service
  • Table 8. CRISPR and Cas Gene Market - Revenue, 2021-2024(US$ Million) - by Product For Product And Service
  • Table 9. CRISPR and Cas Gene Market - Revenue Forecast, 2025-2031(US$ Million) - by Product For Product And Service
  • Table 10. CRISPR and Cas Gene Market - Revenue, 2021-2024(US$ Million) - by Services For Product And Service
  • Table 11. CRISPR and Cas Gene Market - Revenue Forecast, 2025-2031(US$ Million) - by Services For Product And Service
  • Table 12. CRISPR and Cas Gene Market - Revenue, 2021-2024(US$ Million) - by Application
  • Table 13. CRISPR and Cas Gene Market - Revenue Forecast, 2025-2031(US$ Million) - by Application
  • Table 14. CRISPR and Cas Gene Market - Revenue, 2021-2024(US$ Million) - by Biomedical For Application
  • Table 15. CRISPR and Cas Gene Market - Revenue Forecast, 2025-2031(US$ Million) - by Biomedical For Application
  • Table 16. CRISPR and Cas Gene Market - Revenue, 2021-2024(US$ Million) - by End User
  • Table 17. CRISPR and Cas Gene Market - Revenue Forecast, 2025-2031(US$ Million) - by End User
  • Table 18. North America: CRISPR and Cas Gene Market - Revenue, 2021-2024 (US$ Million) - by Product And Service
  • Table 19. North America: CRISPR and Cas Gene Market - Revenue Forecast, 2025-2031 (US$ Million) - by Product And Service
  • Table 20. North America: CRISPR and Cas Gene Market - Revenue, 2021-2024 (US$ Million) - by Product For Product And Service
  • Table 21. North America: CRISPR and Cas Gene Market - Revenue Forecast, 2025-2031 (US$ Million) - by Product For Product And Service
  • Table 22. North America: CRISPR and Cas Gene Market - Revenue, 2021-2024 (US$ Million) - by Services For Product And Service
  • Table 23. North America: CRISPR and Cas Gene Market - Revenue Forecast, 2025-2031 (US$ Million) - by Services For Product And Service
  • Table 24. North America: CRISPR and Cas Gene Market - Revenue, 2021-2024 (US$ Million) - by Application
  • Table 25. North America: CRISPR and Cas Gene Market - Revenue Forecast, 2025-2031 (US$ Million) - by Application
  • Table 26. North America: CRISPR and Cas Gene Market - Revenue, 2021-2024 (US$ Million) - by Biomedical For Application
  • Table 27. North America: CRISPR and Cas Gene Market - Revenue Forecast, 2025-2031 (US$ Million) - by Biomedical For Application
  • Table 28. North America: CRISPR and Cas Gene Market - Revenue, 2021-2024 (US$ Million) - by End User
  • Table 29. North America: CRISPR and Cas Gene Market - Revenue Forecast, 2025-2031 (US$ Million) - by End User
  • Table 30. North America: CRISPR and Cas Gene Market - Revenue, 2021-2024 (US$ Million) - by Country
  • Table 31. North America: CRISPR and Cas Gene Market - Revenue Forecast, 2025-2031 (US$ Million) - by Country
  • Table 32. United States: CRISPR and Cas Gene Market - Revenue, 2021-2024 (US$ Million) - by Product And Service
  • Table 33. United States: CRISPR and Cas Gene Market - Revenue Forecast, 2025-2031 (US$ Million) - by Product And Service
  • Table 34. United States: CRISPR and Cas Gene Market - Revenue, 2021-2024 (US$ Million) - by Product For Product And Service
  • Table 35. United States: CRISPR and Cas Gene Market - Revenue Forecast, 2025-2031 (US$ Million) - by Product For Product And Service
  • Table 36. United States: CRISPR and Cas Gene Market - Revenue, 2021-2024 (US$ Million) - by Services For Product And Service
  • Table 37. United States: CRISPR and Cas Gene Market - Revenue Forecast, 2025-2031 (US$ Million) - by Services For Product And Service
  • Table 38. United States: CRISPR and Cas Gene Market - Revenue, 2021-2024 (US$ Million) - by Application
  • Table 39. United States: CRISPR and Cas Gene Market - Revenue Forecast, 2025-2031 (US$ Million) - by Application
  • Table 40. United States: CRISPR and Cas Gene Market - Revenue, 2021-2024 (US$ Million) - by Biomedical For Application
  • Table 41. United States: CRISPR and Cas Gene Market - Revenue Forecast, 2025-2031 (US$ Million) - by Biomedical For Application
  • Table 42. United States: CRISPR and Cas Gene Market - Revenue, 2021-2024 (US$ Million) - by End User
  • Table 43. United States: CRISPR and Cas Gene Market - Revenue Forecast, 2025-2031 (US$ Million) - by End User
  • Table 44. Canada: CRISPR and Cas Gene Market - Revenue, 2021-2024 (US$ Million) - by Product And Service
  • Table 45. Canada: CRISPR and Cas Gene Market - Revenue Forecast, 2025-2031 (US$ Million) - by Product And Service
  • Table 46. Canada: CRISPR and Cas Gene Market - Revenue, 2021-2024 (US$ Million) - by Product For Product And Service
  • Table 47. Canada: CRISPR and Cas Gene Market - Revenue Forecast, 2025-2031 (US$ Million) - by Product For Product And Service
  • Table 48. Canada: CRISPR and Cas Gene Market - Revenue, 2021-2024 (US$ Million) - by Services For Product And Service
  • Table 49. Canada: CRISPR and Cas Gene Market - Revenue Forecast, 2025-2031 (US$ Million) - by Services For Product And Service
  • Table 50. Canada: CRISPR and Cas Gene Market - Revenue, 2021-2024 (US$ Million) - by Application
  • Table 51. Canada: CRISPR and Cas Gene Market - Revenue Forecast, 2025-2031 (US$ Million) - by Application
  • Table 52. Canada: CRISPR and Cas Gene Market - Revenue, 2021-2024 (US$ Million) - by Biomedical For Application
  • Table 53. Canada: CRISPR and Cas Gene Market - Revenue Forecast, 2025-2031 (US$ Million) - by Biomedical For Application
  • Table 54. Canada: CRISPR and Cas Gene Market - Revenue, 2021-2024 (US$ Million) - by End User
  • Table 55. Canada: CRISPR and Cas Gene Market - Revenue Forecast, 2025-2031 (US$ Million) - by End User
  • Table 56. Mexico: CRISPR and Cas Gene Market - Revenue, 2021-2024 (US$ Million) - by Product And Service
  • Table 57. Mexico: CRISPR and Cas Gene Market - Revenue Forecast, 2025-2031 (US$ Million) - by Product And Service
  • Table 58. Mexico: CRISPR and Cas Gene Market - Revenue, 2021-2024 (US$ Million) - by Product For Product And Service
  • Table 59. Mexico: CRISPR and Cas Gene Market - Revenue Forecast, 2025-2031 (US$ Million) - by Product For Product And Service
  • Table 60. Mexico: CRISPR and Cas Gene Market - Revenue, 2021-2024 (US$ Million) - by Services For Product And Service
  • Table 61. Mexico: CRISPR and Cas Gene Market - Revenue Forecast, 2025-2031 (US$ Million) - by Services For Product And Service
  • Table 62. Mexico: CRISPR and Cas Gene Market - Revenue, 2021-2024 (US$ Million) - by Application
  • Table 63. Mexico: CRISPR and Cas Gene Market - Revenue Forecast, 2025-2031 (US$ Million) - by Application
  • Table 64. Mexico: CRISPR and Cas Gene Market - Revenue, 2021-2024 (US$ Million) - by Biomedical For Application
  • Table 65. Mexico: CRISPR and Cas Gene Market - Revenue Forecast, 2025-2031 (US$ Million) - by Biomedical For Application
  • Table 66. Mexico: CRISPR and Cas Gene Market - Revenue, 2021-2024 (US$ Million) - by End User
  • Table 67. Mexico: CRISPR and Cas Gene Market - Revenue Forecast, 2025-2031 (US$ Million) - by End User
  • Table 68. Europe: CRISPR and Cas Gene Market - Revenue, 2021-2024 (US$ Million) - by Product And Service
  • Table 69. Europe: CRISPR and Cas Gene Market - Revenue Forecast, 2025-2031 (US$ Million) - by Product And Service
  • Table 70. Europe: CRISPR and Cas Gene Market - Revenue, 2021-2024 (US$ Million) - by Product For Product And Service
  • Table 71. Europe: CRISPR and Cas Gene Market - Revenue Forecast, 2025-2031 (US$ Million) - by Product For Product And Service
  • Table 72. Europe: CRISPR and Cas Gene Market - Revenue, 2021-2024 (US$ Million) - by Services For Product And Service
  • Table 73. Europe: CRISPR and Cas Gene Market - Revenue Forecast, 2025-2031 (US$ Million) - by Services For Product And Service
  • Table 74. Europe: CRISPR and Cas Gene Market - Revenue, 2021-2024 (US$ Million) - by Application
  • Table 75. Europe: CRISPR and Cas Gene Market - Revenue Forecast, 2025-2031 (US$ Million) - by Application
  • Table 76. Europe: CRISPR and Cas Gene Market - Revenue, 2021-2024 (US$ Million) - by Biomedical For Application
  • Table 77. Europe: CRISPR and Cas Gene Market - Revenue Forecast, 2025-2031 (US$ Million) - by Biomedical For Application
  • Table 78. Europe: CRISPR and Cas Gene Market - Revenue, 2021-2024 (US$ Million) - by End User
  • Table 79. Europe: CRISPR and Cas Gene Market - Revenue Forecast, 2025-2031 (US$ Million) - by End User
  • Table 80. Europe: CRISPR and Cas Gene Market - Revenue, 2021-2024 (US$ Million) - by Country
  • Table 81. Europe: CRISPR and Cas Gene Market - Revenue Forecast, 2025-2031 (US$ Million) - by Country
  • Table 82. United Kingdom: CRISPR and Cas Gene Market - Revenue, 2021-2024 (US$ Million) - by Product And Service
  • Table 83. United Kingdom: CRISPR and Cas Gene Market - Revenue Forecast, 2025-2031 (US$ Million) - by Product And Service
  • Table 84. United Kingdom: CRISPR and Cas Gene Market - Revenue, 2021-2024 (US$ Million) - by Product For Product And Service
  • Table 85. United Kingdom: CRISPR and Cas Gene Market - Revenue Forecast, 2025-2031 (US$ Million) - by Product For Product And Service
  • Table 86. United Kingdom: CRISPR and Cas Gene Market - Revenue, 2021-2024 (US$ Million) - by Services For Product And Service
  • Table 87. United Kingdom: CRISPR and Cas Gene Market - Revenue Forecast, 2025-2031 (US$ Million) - by Services For Product And Service
  • Table 88. United Kingdom: CRISPR and Cas Gene Market - Revenue, 2021-2024 (US$ Million) - by Application
  • Table 89. United Kingdom: CRISPR and Cas Gene Market - Revenue Forecast, 2025-2031 (US$ Million) - by Application
  • Table 90. United Kingdom: CRISPR and Cas Gene Market - Revenue, 2021-2024 (US$ Million) - by Biomedical For Application
  • Table 91. United Kingdom: CRISPR and Cas Gene Market - Revenue Forecast, 2025-2031 (US$ Million) - by Biomedical For Application
  • Table 92. United Kingdom: CRISPR and Cas Gene Market - Revenue, 2021-2024 (US$ Million) - by End User
  • Table 93. United Kingdom: CRISPR and Cas Gene Market - Revenue Forecast, 2025-2031 (US$ Million) - by End User
  • Table 94. Germany: CRISPR and Cas Gene Market - Revenue, 2021-2024 (US$ Million) - by Product And Service
  • Table 95. Germany: CRISPR and Cas Gene Market - Revenue Forecast, 2025-2031 (US$ Million) - by Product And Service
  • Table 96. Germany: CRISPR and Cas Gene Market - Revenue, 2021-2024 (US$ Million) - by Product For Product And Service
  • Table 97. Germany: CRISPR and Cas Gene Market - Revenue Forecast, 2025-2031 (US$ Million) - by Product For Product And Service
  • Table 98. Germany: CRISPR and Cas Gene Market - Revenue, 2021-2024 (US$ Million) - by Services For Product And Service
  • Table 99. Germany: CRISPR and Cas Gene Market - Revenue Forecast, 2025-2031 (US$ Million) - by Services For Product And Service
  • Table 100. Germany: CRISPR and Cas Gene Market - Revenue, 2021-2024 (US$ Million) - by Application
  • Table 101. Germany: CRISPR and Cas Gene Market - Revenue Forecast, 2025-2031 (US$ Million) - by Application
  • Table 102. Germany: CRISPR and Cas Gene Market - Revenue, 2021-2024 (US$ Million) - by Biomedical For Application
  • Table 103. Germany: CRISPR and Cas Gene Market - Revenue Forecast, 2025-2031 (US$ Million) - by Biomedical For Application
  • Table 104. Germany: CRISPR and Cas Gene Market - Revenue, 2021-2024 (US$ Million) - by End User
  • Table 105. Germany: CRISPR and Cas Gene Market - Revenue Forecast, 2025-2031 (US$ Million) - by End User
  • Table 106. France: CRISPR and Cas Gene Market - Revenue, 2021-2024 (US$ Million) - by Product And Service
  • Table 107. France: CRISPR and Cas Gene Market - Revenue Forecast, 2025-2031 (US$ Million) - by Product And Service
  • Table 108. France: CRISPR and Cas Gene Market - Revenue, 2021-2024 (US$ Million) - by Product For Product And Service
  • Table 109. France: CRISPR and Cas Gene Market - Revenue Forecast, 2025-2031 (US$ Million) - by Product For Product And Service
  • Table 110. France: CRISPR and Cas Gene Market - Revenue, 2021-2024 (US$ Million) - by Services For Product And Service
  • Table 111. France: CRISPR and Cas Gene Market - Revenue Forecast, 2025-2031 (US$ Million) - by Services For Product And Service
  • Table 112. France: CRISPR and Cas Gene Market - Revenue, 2021-2024 (US$ Million) - by Application
  • Table 113. France: CRISPR and Cas Gene Market - Revenue Forecast, 2025-2031 (US$ Million) - by Application
  • Table 114. France: CRISPR and Cas Gene Market - Revenue, 2021-2024 (US$ Million) - by Biomedical For Application
  • Table 115. France: CRISPR and Cas Gene Market - Revenue Forecast, 2025-2031 (US$ Million) - by Biomedical For Application
  • Table 116. France: CRISPR and Cas Gene Market - Revenue, 2021-2024 (US$ Million) - by End User
  • Table 117. France: CRISPR and Cas Gene Market - Revenue Forecast, 2025-2031 (US$ Million) - by End User
  • Table 118. Italy: CRISPR and Cas Gene Market - Revenue, 2021-2024 (US$ Million) - by Product And Service
  • Table 119. Italy: CRISPR and Cas Gene Market - Revenue Forecast, 2025-2031 (US$ Million) - by Product And Service
  • Table 120. Italy: CRISPR and Cas Gene Market - Revenue, 2021-2024 (US$ Million) - by Product For Product And Service
  • Table 121. Italy: CRISPR and Cas Gene Market - Revenue Forecast, 2025-2031 (US$ Million) - by Product For Product And Service
  • Table 122. Italy: CRISPR and Cas Gene Market - Revenue, 2021-2024 (US$ Million) - by Services For Product And Service
  • Table 123. Italy: CRISPR and Cas Gene Market - Revenue Forecast, 2025-2031 (US$ Million) - by Services For Product And Service
  • Table 124. Italy: CRISPR and Cas Gene Market - Revenue, 2021-2024 (US$ Million) - by Application
  • Table 125. Italy: CRISPR and Cas Gene Market - Revenue Forecast, 2025-2031 (US$ Million) - by Application
  • Table 126. Italy: CRISPR and Cas Gene Market - Revenue, 2021-2024 (US$ Million) - by Biomedical For Application
  • Table 127. Italy: CRISPR and Cas Gene Market - Revenue Forecast, 2025-2031 (US$ Million) - by Biomedical For Application
  • Table 128. Italy: CRISPR and Cas Gene Market - Revenue, 2021-2024 (US$ Million) - by End User
  • Table 129. Italy: CRISPR and Cas Gene Market - Revenue Forecast, 2025-2031 (US$ Million) - by End User
  • Table 130. Spain: CRISPR and Cas Gene Market - Revenue, 2021-2024 (US$ Million) - by Product And Service
  • Table 131. Spain: CRISPR and Cas Gene Market - Revenue Forecast, 2025-2031 (US$ Million) - by Product And Service
  • Table 132. Spain: CRISPR and Cas Gene Market - Revenue, 2021-2024 (US$ Million) - by Product For Product And Service
  • Table 133. Spain: CRISPR and Cas Gene Market - Revenue Forecast, 2025-2031 (US$ Million) - by Product For Product And Service
  • Table 134. Spain: CRISPR and Cas Gene Market - Revenue, 2021-2024 (US$ Million) - by Services For Product And Service
  • Table 135. Spain: CRISPR and Cas Gene Market - Revenue Forecast, 2025-2031 (US$ Million) - by Services For Product And Service
  • Table 136. Spain: CRISPR and Cas Gene Market - Revenue, 2021-2024 (US$ Million) - by Application
  • Table 137. Spain: CRISPR and Cas Gene Market - Revenue Forecast, 2025-2031 (US$ Million) - by Application
  • Table 138. Spain: CRISPR and Cas Gene Market - Revenue, 2021-2024 (US$ Million) - by Biomedical For Application
  • Table 139. Spain: CRISPR and Cas Gene Market - Revenue Forecast, 2025-2031 (US$ Million) - by Biomedical For Application
  • Table 140. Spain: CRISPR and Cas Gene Market - Revenue, 2021-2024 (US$ Million) - by End User
  • Table 141. Spain: CRISPR and Cas Gene Market - Revenue Forecast, 2025-2031 (US$ Million) - by End User
  • Table 142. Rest of Europe: CRISPR and Cas Gene Market - Revenue, 2021-2024 (US$ Million) - by Product And Service
  • Table 143. Rest of Europe: CRISPR and Cas Gene Market - Revenue Forecast, 2025-2031 (US$ Million) - by Product And Service
  • Table 144. Rest of Europe: CRISPR and Cas Gene Market - Revenue, 2021-2024 (US$ Million) - by Product For Product And Service
  • Table 145. Rest of Europe: CRISPR and Cas Gene Market - Revenue Forecast, 2025-2031 (US$ Million) - by Product For Product And Service
  • Table 146. Rest of Europe: CRISPR and Cas Gene Market - Revenue, 2021-2024 (US$ Million) - by Services For Product And Service
  • Table 147. Rest of Europe: CRISPR and Cas Gene Market - Revenue Forecast, 2025-2031 (US$ Million) - by Services For Product And Service
  • Table 148. Rest of Europe: CRISPR and Cas Gene Market - Revenue, 2021-2024 (US$ Million) - by Application
  • Table 149. Rest of Europe: CRISPR and Cas Gene Market - Revenue Forecast, 2025-2031 (US$ Million) - by Application
  • Table 150. Rest of Europe: CRISPR and Cas Gene Market - Revenue, 2021-2024 (US$ Million) - by Biomedical For Application
  • Table 151. Rest of Europe: CRISPR and Cas Gene Market - Revenue Forecast, 2025-2031 (US$ Million) - by Biomedical For Application
  • Table 152. Rest of Europe: CRISPR and Cas Gene Market - Revenue, 2021-2024 (US$ Million) - by End User
  • Table 153. Rest of Europe: CRISPR and Cas Gene Market - Revenue Forecast, 2025-2031 (US$ Million) - by End User
  • Table 154. Asia Pacific: CRISPR and Cas Gene Market - Revenue, 2021-2024 (US$ Million) - by Product And Service
  • Table 155. Asia Pacific: CRISPR and Cas Gene Market - Revenue Forecast, 2025-2031 (US$ Million) - by Product And Service
  • Table 156. Asia Pacific: CRISPR and Cas Gene Market - Revenue, 2021-2024 (US$ Million) - by Product For Product And Service
  • Table 157. Asia Pacific: CRISPR and Cas Gene Market - Revenue Forecast, 2025-2031 (US$ Million) - by Product For Product And Service
  • Table 158. Asia Pacific: CRISPR and Cas Gene Market - Revenue, 2021-2024 (US$ Million) - by Services For Product And Service
  • Table 159. Asia Pacific: CRISPR and Cas Gene Market - Revenue Forecast, 2025-2031 (US$ Million) - by Services For Product And Service
  • Table 160. Asia Pacific: CRISPR and Cas Gene Market - Revenue, 2021-2024 (US$ Million) - by Application
  • Table 161. Asia Pacific: CRISPR and Cas Gene Market - Revenue Forecast, 2025-2031 (US$ Million) - by Application
  • Table 162. Asia Pacific: CRISPR and Cas Gene Market - Revenue, 2021-2024 (US$ Million) - by Biomedical For Application
  • Table 163. Asia Pacific: CRISPR and Cas Gene Market - Revenue Forecast, 2025-2031 (US$ Million) - by Biomedical For Application
  • Table 164. Asia Pacific: CRISPR and Cas Gene Market - Revenue, 2021-2024 (US$ Million) - by End User
  • Table 165. Asia Pacific: CRISPR and Cas Gene Market - Revenue Forecast, 2025-2031 (US$ Million) - by End User
  • Table 166. Asia Pacific: CRISPR and Cas Gene Market - Revenue, 2021-2024 (US$ Million) - by Country
  • Table 167. Asia Pacific: CRISPR and Cas Gene Market - Revenue Forecast, 2025-2031 (US$ Million) - by Country
  • Table 168. China: CRISPR and Cas Gene Market - Revenue, 2021-2024 (US$ Million) - by Product And Service
  • Table 169. China: CRISPR and Cas Gene Market - Revenue Forecast, 2025-2031 (US$ Million) - by Product And Service
  • Table 170. China: CRISPR and Cas Gene Market - Revenue, 2021-2024 (US$ Million) - by Product For Product And Service
  • Table 171. China: CRISPR and Cas Gene Market - Revenue Forecast, 2025-2031 (US$ Million) - by Product For Product And Service
  • Table 172. China: CRISPR and Cas Gene Market - Revenue, 2021-2024 (US$ Million) - by Services For Product And Service
  • Table 173. China: CRISPR and Cas Gene Market - Revenue Forecast, 2025-2031 (US$ Million) - by Services For Product And Service
  • Table 174. China: CRISPR and Cas Gene Market - Revenue, 2021-2024 (US$ Million) - by Application
  • Table 175. China: CRISPR and Cas Gene Market - Revenue Forecast, 2025-2031 (US$ Million) - by Application
  • Table 176. China: CRISPR and Cas Gene Market - Revenue, 2021-2024 (US$ Million) - by Biomedical For Application
  • Table 177. China: CRISPR and Cas Gene Market - Revenue Forecast, 2025-2031 (US$ Million) - by Biomedical For Application
  • Table 178. China: CRISPR and Cas Gene Market - Revenue, 2021-2024 (US$ Million) - by End User
  • Table 179. China: CRISPR and Cas Gene Market - Revenue Forecast, 2025-2031 (US$ Million) - by End User
  • Table 180. Japan: CRISPR and Cas Gene Market - Revenue, 2021-2024 (US$ Million) - by Product And Service
  • Table 181. Japan: CRISPR and Cas Gene Market - Revenue Forecast, 2025-2031 (US$ Million) - by Product And Service
  • Table 182. Japan: CRISPR and Cas Gene Market - Revenue, 2021-2024 (US$ Million) - by Product For Product And Service
  • Table 183. Japan: CRISPR and Cas Gene Market - Revenue Forecast, 2025-2031 (US$ Million) - by Product For Product And Service
  • Table 184. Japan: CRISPR and Cas Gene Market - Revenue, 2021-2024 (US$ Million) - by Services For Product And Service
  • Table 185. Japan: CRISPR and Cas Gene Market - Revenue Forecast, 2025-2031 (US$ Million) - by Services For Product And Service
  • Table 186. Japan: CRISPR and Cas Gene Market - Revenue, 2021-2024 (US$ Million) - by Application
  • Table 187. Japan: CRISPR and Cas Gene Market - Revenue Forecast, 2025-2031 (US$ Million) - by Application
  • Table 188. Japan: CRISPR and Cas Gene Market - Revenue, 2021-2024 (US$ Million) - by Biomedical For Application
  • Table 189. Japan: CRISPR and Cas Gene Market - Revenue Forecast, 2025-2031 (US$ Million) - by Biomedical For Application
  • Table 190. Japan: CRISPR and Cas Gene Market - Revenue, 2021-2024 (US$ Million) - by End User
  • Table 191. Japan: CRISPR and Cas Gene Market - Revenue Forecast, 2025-2031 (US$ Million) - by End User
  • Table 192. India: CRISPR and Cas Gene Market - Revenue, 2021-2024 (US$ Million) - by Product And Service
  • Table 193. India: CRISPR and Cas Gene Market - Revenue Forecast, 2025-2031 (US$ Million) - by Product And Service
  • Table 194. India: CRISPR and Cas Gene Market - Revenue, 2021-2024 (US$ Million) - by Product For Product And Service
  • Table 195. India: CRISPR and Cas Gene Market - Revenue Forecast, 2025-2031 (US$ Million) - by Product For Product And Service
  • Table 196. India: CRISPR and Cas Gene Market - Revenue, 2021-2024 (US$ Million) - by Services For Product And Service
  • Table 197. India: CRISPR and Cas Gene Market - Revenue Forecast, 2025-2031 (US$ Million) - by Services For Product And Service
  • Table 198. India: CRISPR and Cas Gene Market - Revenue, 2021-2024 (US$ Million) - by Application
  • Table 199. India: CRISPR and Cas Gene Market - Revenue Forecast, 2025-2031 (US$ Million) - by Application
  • Table 200. India: CRISPR and Cas Gene Market - Revenue, 2021-2024 (US$ Million) - by Biomedical For Application
  • Table 201. India: CRISPR and Cas Gene Market - Revenue Forecast, 2025-2031 (US$ Million) - by Biomedical For Application
  • Table 202. India: CRISPR and Cas Gene Market - Revenue, 2021-2024 (US$ Million) - by End User
  • Table 203. India: CRISPR and Cas Gene Market - Revenue Forecast, 2025-2031 (US$ Million) - by End User
  • Table 204. Australia: CRISPR and Cas Gene Market - Revenue, 2021-2024 (US$ Million) - by Product And Service
  • Table 205. Australia: CRISPR and Cas Gene Market - Revenue Forecast, 2025-2031 (US$ Million) - by Product And Service
  • Table 206. Australia: CRISPR and Cas Gene Market - Revenue, 2021-2024 (US$ Million) - by Product For Product And Service
  • Table 207. Australia: CRISPR and Cas Gene Market - Revenue Forecast, 2025-2031 (US$ Million) - by Product For Product And Service
  • Table 208. Australia: CRISPR and Cas Gene Market - Revenue, 2021-2024 (US$ Million) - by Services For Product And Service
  • Table 209. Australia: CRISPR and Cas Gene Market - Revenue Forecast, 2025-2031 (US$ Million) - by Services For Product And Service
  • Table 210. Australia: CRISPR and Cas Gene Market - Revenue, 2021-2024 (US$ Million) - by Application
  • Table 211. Australia: CRISPR and Cas Gene Market - Revenue Forecast, 2025-2031 (US$ Million) - by Application
  • Table 212. Australia: CRISPR and Cas Gene Market - Revenue, 2021-2024 (US$ Million) - by Biomedical For Application
  • Table 213. Australia: CRISPR and Cas Gene Market - Revenue Forecast, 2025-2031 (US$ Million) - by Biomedical For Application
  • Table 214. Australia: CRISPR and Cas Gene Market - Revenue, 2021-2024 (US$ Million) - by End User
  • Table 215. Australia: CRISPR and Cas Gene Market - Revenue Forecast, 2025-2031 (US$ Million) - by End User
  • Table 216. South Korea: CRISPR and Cas Gene Market - Revenue, 2021-2024 (US$ Million) - by Product And Service
  • Table 217. South Korea: CRISPR and Cas Gene Market - Revenue Forecast, 2025-2031 (US$ Million) - by Product And Service
  • Table 218. South Korea: CRISPR and Cas Gene Market - Revenue, 2021-2024 (US$ Million) - by Product For Product And Service
  • Table 219. South Korea: CRISPR and Cas Gene Market - Revenue Forecast, 2025-2031 (US$ Million) - by Product For Product And Service
  • Table 220. South Korea: CRISPR and Cas Gene Market - Revenue, 2021-2024 (US$ Million) - by Services For Product And Service
  • Table 221. South Korea: CRISPR and Cas Gene Market - Revenue Forecast, 2025-2031 (US$ Million) - by Services For Product And Service
  • Table 222. South Korea: CRISPR and Cas Gene Market - Revenue, 2021-2024 (US$ Million) - by Application
  • Table 223. South Korea: CRISPR and Cas Gene Market - Revenue Forecast, 2025-2031 (US$ Million) - by Application
  • Table 224. South Korea: CRISPR and Cas Gene Market - Revenue, 2021-2024 (US$ Million) - by Biomedical For Application
  • Table 225. South Korea: CRISPR and Cas Gene Market - Revenue Forecast, 2025-2031 (US$ Million) - by Biomedical For Application
  • Table 226. South Korea: CRISPR and Cas Gene Market - Revenue, 2021-2024 (US$ Million) - by End User
  • Table 227. South Korea: CRISPR and Cas Gene Market - Revenue Forecast, 2025-2031 (US$ Million) - by End User
  • Table 228. Rest of APAC: CRISPR and Cas Gene Market - Revenue, 2021-2024 (US$ Million) - by Product And Service
  • Table 229. Rest of APAC: CRISPR and Cas Gene Market - Revenue Forecast, 2025-2031 (US$ Million) - by Product And Service
  • Table 230. Rest of APAC: CRISPR and Cas Gene Market - Revenue, 2021-2024 (US$ Million) - by Product For Product And Service
  • Table 231. Rest of APAC: CRISPR and Cas Gene Market - Revenue Forecast, 2025-2031 (US$ Million) - by Product For Product And Service
  • Table 232. Rest of APAC: CRISPR and Cas Gene Market - Revenue, 2021-2024 (US$ Million) - by Services For Product And Service
  • Table 233. Rest of APAC: CRISPR and Cas Gene Market - Revenue Forecast, 2025-2031 (US$ Million) - by Services For Product And Service
  • Table 234. Rest of APAC: CRISPR and Cas Gene Market - Revenue, 2021-2024 (US$ Million) - by Application
  • Table 235. Rest of APAC: CRISPR and Cas Gene Market - Revenue Forecast, 2025-2031 (US$ Million) - by Application
  • Table 236. Rest of APAC: CRISPR and Cas Gene Market - Revenue, 2021-2024 (US$ Million) - by Biomedical For Application
  • Table 237. Rest of APAC: CRISPR and Cas Gene Market - Revenue Forecast, 2025-2031 (US$ Million) - by Biomedical For Application
  • Table 238. Rest of APAC: CRISPR and Cas Gene Market - Revenue, 2021-2024 (US$ Million) - by End User
  • Table 239. Rest of APAC: CRISPR and Cas Gene Market - Revenue Forecast, 2025-2031 (US$ Million) - by End User
  • Table 240. Middle East and Africa: CRISPR and Cas Gene Market - Revenue, 2021-2024 (US$ Million) - by Product And Service
  • Table 241. Middle East and Africa: CRISPR and Cas Gene Market - Revenue Forecast, 2025-2031 (US$ Million) - by Product And Service
  • Table 242. Middle East and Africa: CRISPR and Cas Gene Market - Revenue, 2021-2024 (US$ Million) - by Product For Product And Service
  • Table 243. Middle East and Africa: CRISPR and Cas Gene Market - Revenue Forecast, 2025-2031 (US$ Million) - by Product For Product And Service
  • Table 244. Middle East and Africa: CRISPR and Cas Gene Market - Revenue, 2021-2024 (US$ Million) - by Services For Product And Service
  • Table 245. Middle East and Africa: CRISPR and Cas Gene Market - Revenue Forecast, 2025-2031 (US$ Million) - by Services For Product And Service
  • Table 246. Middle East and Africa: CRISPR and Cas Gene Market - Revenue, 2021-2024 (US$ Million) - by Application
  • Table 247. Middle East and Africa: CRISPR and Cas Gene Market - Revenue Forecast, 2025-2031 (US$ Million) - by Application
  • Table 248. Middle East and Africa: CRISPR and Cas Gene Market - Revenue, 2021-2024 (US$ Million) - by Biomedical For Application
  • Table 249. Middle East and Africa: CRISPR and Cas Gene Market - Revenue Forecast, 2025-2031 (US$ Million) - by Biomedical For Application
  • Table 250. Middle East and Africa: CRISPR and Cas Gene Market - Revenue, 2021-2024 (US$ Million) - by End User
  • Table 251. Middle East and Africa: CRISPR and Cas Gene Market - Revenue Forecast, 2025-2031 (US$ Million) - by End User
  • Table 252. Middle East and Africa: CRISPR and Cas Gene Market - Revenue, 2021-2024 (US$ Million) - by Country
  • Table 253. Middle East and Africa: CRISPR and Cas Gene Market - Revenue Forecast, 2025-2031 (US$ Million) - by Country
  • Table 254. Saudi Arabia: CRISPR and Cas Gene Market - Revenue, 2021-2024 (US$ Million) - by Product And Service
  • Table 255. Saudi Arabia: CRISPR and Cas Gene Market - Revenue Forecast, 2025-2031 (US$ Million) - by Product And Service
  • Table 256. Saudi Arabia: CRISPR and Cas Gene Market - Revenue, 2021-2024 (US$ Million) - by Product For Product And Service
  • Table 257. Saudi Arabia: CRISPR and Cas Gene Market - Revenue Forecast, 2025-2031 (US$ Million) - by Product For Product And Service
  • Table 258. Saudi Arabia: CRISPR and Cas Gene Market - Revenue, 2021-2024 (US$ Million) - by Services For Product And Service
  • Table 259. Saudi Arabia: CRISPR and Cas Gene Market - Revenue Forecast, 2025-2031 (US$ Million) - by Services For Product And Service
  • Table 260. Saudi Arabia: CRISPR and Cas Gene Market - Revenue, 2021-2024 (US$ Million) - by Application
  • Table 261. Saudi Arabia: CRISPR and Cas Gene Market - Revenue Forecast, 2025-2031 (US$ Million) - by Application
  • Table 262. Saudi Arabia: CRISPR and Cas Gene Market - Revenue, 2021-2024 (US$ Million) - by Biomedical For Application
  • Table 263. Saudi Arabia: CRISPR and Cas Gene Market - Revenue Forecast, 2025-2031 (US$ Million) - by Biomedical For Application
  • Table 264. Saudi Arabia: CRISPR and Cas Gene Market - Revenue, 2021-2024 (US$ Million) - by End User
  • Table 265. Saudi Arabia: CRISPR and Cas Gene Market - Revenue Forecast, 2025-2031 (US$ Million) - by End User
  • Table 266. South Africa: CRISPR and Cas Gene Market - Revenue, 2021-2024 (US$ Million) - by Product And Service
  • Table 267. South Africa: CRISPR and Cas Gene Market - Revenue Forecast, 2025-2031 (US$ Million) - by Product And Service
  • Table 268. South Africa: CRISPR and Cas Gene Market - Revenue, 2021-2024 (US$ Million) - by Product For Product And Service
  • Table 269. South Africa: CRISPR and Cas Gene Market - Revenue Forecast, 2025-2031 (US$ Million) - by Product For Product And Service
  • Table 270. South Africa: CRISPR and Cas Gene Market - Revenue, 2021-2024 (US$ Million) - by Services For Product And Service
  • Table 271. South Africa: CRISPR and Cas Gene Market - Revenue Forecast, 2025-2031 (US$ Million) - by Services For Product And Service
  • Table 272. South Africa: CRISPR and Cas Gene Market - Revenue, 2021-2024 (US$ Million) - by Application
  • Table 273. South Africa: CRISPR and Cas Gene Market - Revenue Forecast, 2025-2031 (US$ Million) - by Application
  • Table 274. South Africa: CRISPR and Cas Gene Market - Revenue, 2021-2024 (US$ Million) - by Biomedical For Application
  • Table 275. South Africa: CRISPR and Cas Gene Market - Revenue Forecast, 2025-2031 (US$ Million) - by Biomedical For Application
  • Table 276. South Africa: CRISPR and Cas Gene Market - Revenue, 2021-2024 (US$ Million) - by End User
  • Table 277. South Africa: CRISPR and Cas Gene Market - Revenue Forecast, 2025-2031 (US$ Million) - by End User
  • Table 278. United Arab Emirates: CRISPR and Cas Gene Market - Revenue, 2021-2024 (US$ Million) - by Product And Service
  • Table 279. United Arab Emirates: CRISPR and Cas Gene Market - Revenue Forecast, 2025-2031 (US$ Million) - by Product And Service
  • Table 280. United Arab Emirates: CRISPR and Cas Gene Market - Revenue, 2021-2024 (US$ Million) - by Product For Product And Service
  • Table 281. United Arab Emirates: CRISPR and Cas Gene Market - Revenue Forecast, 2025-2031 (US$ Million) - by Product For Product And Service
  • Table 282. United Arab Emirates: CRISPR and Cas Gene Market - Revenue, 2021-2024 (US$ Million) - by Services For Product And Service
  • Table 283. United Arab Emirates: CRISPR and Cas Gene Market - Revenue Forecast, 2025-2031 (US$ Million) - by Services For Product And Service
  • Table 284. United Arab Emirates: CRISPR and Cas Gene Market - Revenue, 2021-2024 (US$ Million) - by Application
  • Table 285. United Arab Emirates: CRISPR and Cas Gene Market - Revenue Forecast, 2025-2031 (US$ Million) - by Application
  • Table 286. United Arab Emirates: CRISPR and Cas Gene Market - Revenue, 2021-2024 (US$ Million) - by Biomedical For Application
  • Table 287. United Arab Emira

List Of Figures

  • Figure 1. CRISPR and Cas Gene Market - Value Chain Analysis
  • Figure 2. Pest Analysis
  • Figure 3. CRISPR and Cas Gene Market - Key Industry Dynamics
  • Figure 4. Impact Analysis of Drivers and Restraints
  • Figure 5. CRISPR and Cas Gene Market Revenue (US$ Million), 2021-2031
  • Figure 6. CRISPR and Cas Gene Market Share (%) - by Product And Service (2024 and 2031)
  • Figure 7. Product: CRISPR and Cas Gene Market -Revenue and Forecasts, 2021-2031 (US$ Million)
  • Figure 8. Services: CRISPR and Cas Gene Market -Revenue and Forecasts, 2021-2031 (US$ Million)
  • Figure 9. CRISPR and Cas Gene Market Share (%) - by Application (2024 and 2031)
  • Figure 10. Biomedical: CRISPR and Cas Gene Market -Revenue and Forecasts, 2021-2031 (US$ Million)
  • Figure 11. Agriculture: CRISPR and Cas Gene Market -Revenue and Forecasts, 2021-2031 (US$ Million)
  • Figure 12. CRISPR and Cas Gene Market Share (%) - by End User (2024 and 2031)
  • Figure 13. Biotechnology and Pharmaceutical Companies: CRISPR and Cas Gene Market -Revenue and Forecasts, 2021-2031 (US$ Million)
  • Figure 14. Academics and Government Research Institutes: CRISPR and Cas Gene Market -Revenue and Forecasts, 2021-2031 (US$ Million)
  • Figure 15. Contract Research Organizations (CRO) and CDMOs: CRISPR and Cas Gene Market -Revenue and Forecasts, 2021-2031 (US$ Million)
  • Figure 16. CRISPR and Cas Gene Market Breakdown by Geography, 2024 and 2031
  • Figure 17. North America: CRISPR and Cas Gene Market Revenue and Forecasts, 2021-2031 (US$ Million)
  • Figure 18. North America: CRISPR and Cas Gene Market Breakdown by Key Countries, 2024 and 2031 (%)
  • Figure 19. United States: CRISPR and Cas Gene Market Revenue and Forecasts, 2021-2031 (US$ Million)
  • Figure 20. Canada: CRISPR and Cas Gene Market Revenue and Forecasts, 2021-2031 (US$ Million)
  • Figure 21. Mexico: CRISPR and Cas Gene Market Revenue and Forecasts, 2021-2031 (US$ Million)
  • Figure 22. Europe: CRISPR and Cas Gene Market Revenue and Forecasts, 2021-2031 (US$ Million)
  • Figure 23. Europe: CRISPR and Cas Gene Market Breakdown by Key Countries, 2024 and 2031 (%)
  • Figure 24. United Kingdom: CRISPR and Cas Gene Market Revenue and Forecasts, 2021-2031 (US$ Million)
  • Figure 25. Germany: CRISPR and Cas Gene Market Revenue and Forecasts, 2021-2031 (US$ Million)
  • Figure 26. France: CRISPR and Cas Gene Market Revenue and Forecasts, 2021-2031 (US$ Million)
  • Figure 27. Italy: CRISPR and Cas Gene Market Revenue and Forecasts, 2021-2031 (US$ Million)
  • Figure 28. Spain: CRISPR and Cas Gene Market Revenue and Forecasts, 2021-2031 (US$ Million)
  • Figure 29. Rest of Europe: CRISPR and Cas Gene Market Revenue and Forecasts, 2021-2031 (US$ Million)
  • Figure 30. Asia Pacific: CRISPR and Cas Gene Market Revenue and Forecasts, 2021-2031 (US$ Million)
  • Figure 31. Asia Pacific: CRISPR and Cas Gene Market Breakdown by Key Countries, 2024 and 2031 (%)
  • Figure 32. China: CRISPR and Cas Gene Market Revenue and Forecasts, 2021-2031 (US$ Million)
  • Figure 33. Japan: CRISPR and Cas Gene Market Revenue and Forecasts, 2021-2031 (US$ Million)
  • Figure 34. India: CRISPR and Cas Gene Market Revenue and Forecasts, 2021-2031 (US$ Million)
  • Figure 35. Australia: CRISPR and Cas Gene Market Revenue and Forecasts, 2021-2031 (US$ Million)
  • Figure 36. South Korea: CRISPR and Cas Gene Market Revenue and Forecasts, 2021-2031 (US$ Million)
  • Figure 37. Rest of APAC: CRISPR and Cas Gene Market Revenue and Forecasts, 2021-2031 (US$ Million)
  • Figure 38. Middle East and Africa: CRISPR and Cas Gene Market Revenue and Forecasts, 2021-2031 (US$ Million)
  • Figure 39. Middle East and Africa: CRISPR and Cas Gene Market Breakdown by Key Countries, 2024 and 2031 (%)
  • Figure 40. Saudi Arabia: CRISPR and Cas Gene Market Revenue and Forecasts, 2021-2031 (US$ Million)
  • Figure 41. South Africa: CRISPR and Cas Gene Market Revenue and Forecasts, 2021-2031 (US$ Million)
  • Figure 42. United Arab Emirates: CRISPR and Cas Gene Market Revenue and Forecasts, 2021-2031 (US$ Million)
  • Figure 43. Rest of Middle East and Africa: CRISPR and Cas Gene Market Revenue and Forecasts, 2021-2031 (US$ Million)
  • Figure 44. South and Central America: CRISPR and Cas Gene Market Revenue and Forecasts, 2021-2031 (US$ Million)
  • Figure 45. South and Central America: CRISPR and Cas Gene Market Breakdown by Key Countries, 2024 and 2031 (%)
  • Figure 46. Brazil: CRISPR and Cas Gene Market Revenue and Forecasts, 2021-2031 (US$ Million)
  • Figure 47. Argentina: CRISPR and Cas Gene Market Revenue and Forecasts, 2021-2031 (US$ Million)
  • Figure 48. Rest of South and Central America: CRISPR and Cas Gene Market Revenue and Forecasts, 2021-2031 (US$ Million)
  • Figure 49. Bottom-Up Approach and Top-Down Approach